Weekly Communique #32
19 November, 2020
WEEK IN REVIEW BREAKING NEWS: Australian-led REMAP-CAP Trial reports benefit of tocilizumab for critically ill patients with COVID-19. The REMAP-CAP investigators led by Prof Steve Webb, Monash University, have this evening issued a global media release reporting early findings after the treatment arm investigating the effect of immune modulator tocilizumab met its combination end-point. The release reports that critically ill patients receiving...